Skip to content
SearchContact UsDirectionsHome
Whitehead Institute for Biomedical Research
About WhiteheadFaculty and ResearchResearch NewsPublic ProgramsCareer OpportunitiesSupport Whitehead
Research News
Search News Archives

On Topic

Paradigm Magazine

Discovery Newsletter

Fact Sheets

Video Gallery

Podcast

For the News Media

Sign Up for News

About Paradigm

Published twice a year, Paradigm magazine reports on life sciences research at Whitehead Institute and beyond, exploring science and its role in the social, scientific and political world around us.







Electronic archives

Fall 2007
Spring 2007
Fall 2006

PDFs of issues

Spring 2008 (8.1 MB)
Fall 2007 (5.0 MB)
Spring 2007 (2.1 MB)
Fall 2006 (2.1 MB)
Spring 2006 (5.8 MB)
Fall 2005 (2.2 MB)
Spring 2005 (1.8 MB)
Fall 2004 (1.6 MB)
Spring 2004 (1.1 MB)
Winter 2003 (3 MB)

whitehead home > research news > paradigm
Spring 2007 issue of Paradigm
3 Qs about cancer: Why do discoveries take so long to reach the clinic?
When your genes aren't to blame, what is?
Is tumor sequencing ready to ramp up?
Structure typical of melanoma

Also in this issue:

Research stories


Network news
Hui Ge sifts through oceans of data to explore how genes collaborate

Biofuels and the gene pool
The power of yeast genetics might make ethanol fuel much more cost-effective

The RNA connection
Joint projects by David Bartel's lab highlight the crucial role of collaborations

Mouth to mouth
What can a frog mouth tell us about human birth defects?

Whiteboard (0.2 mb pdf or 6.8 mb jpg)
The link between epigenetics and cancer

Science and society


Science for me and YouTube
Why Web video is changing how we learn about biomedical research

Biology's big tent
Meet some of the young researchers pouring into life sciences from other fields

Targeting the agents of disease
In the war on infectious disease, are we spending smart?

Fast FAQs: Promises and realities in embryonic stem cell research
For all the controversies, it's still early days for this science

Gleevec pills
A slow saga of success
Follow the decades-long story of Gleevec, a drug that treats chronic myelogenous leukemia.
[read more]


microadenoma
The unusual suspect
Cancer researchers look beyond the genome to the epigenome.
[read more]


Contact Webmaster